On Tuesday, Defiance ETFs launched NVOX, the primary single-stock leveraged ETF centered on Danish pharmaceutical big Novo Nordisk A/S NVO.
The ETF presents retail buyers double the every day lengthy publicity to Novo Nordisk’s inventory value adjustments with out requiring a margin account, presenting an progressive buying and selling possibility.
Nevertheless, NVOX carries heightened danger because of its single-stock nature and doesn’t make investments immediately in Novo Nordisk shares.
Additionally Learn: Massive Pharma Pushes To Revise Biden-era Medicare Drug Value Negotiation Regulation Below Trump
Sylvia Jablonski, CEO of Defiance ETFs, emphasised the strategic significance of NVOX, highlighting Novo Nordisk’s central position within the booming weight reduction market.
The corporate produces the favored medicine Ozempic and Wegovy, which have positioned it as a key participant in an trade with important progress potential.
Novo Nordisk reported that within the third quarter of 2024, Wegovy gross sales reached 17.30 billion Danish kroner, up 81%, and Ozempic gross sales elevated 26% at fixed forex to 29.80 billion Danish kroner.
Jablonski described NVOX as a instrument for buyers seeking to capitalize on this multi-trillion-dollar alternative.
Established in 2018, Defiance ETFs makes a speciality of earnings and thematic investing, providing merchandise tailor-made for tactical buying and selling alternatives. Its suite of ETFs spans disruptive applied sciences resembling synthetic intelligence and quantum computing.
In August, Defiance ETFs launched LLYX the Defiance Day by day Goal 2X Lengthy LLY ETF, which seeks every day leveraged funding outcomes of two instances (200%) the every day share change within the share value of Eli Lilly And Co LLY.
Based on analysis revealed in JAMA Community Open, using anti-obesity drugs, together with glucagon-like peptide-1 receptor agonists, was related to decrease incidence and recurrence of alcohol use dysfunction.
Value Motion: NVO inventory is up 2.02% at $110.86 in the course of the premarket session finally examine Tuesday.
Learn Subsequent:
Picture through Shutterstock
Market Information and Knowledge dropped at you by Benzinga APIs
© 2024 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
